deltatrials
Completed PHASE3 NCT00628719

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

A Phase III Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Single Infusion of Liposomal Amphotericin B in Patients With Visceral Leishmaniasis

Sponsor: Banaras Hindu University

Conditions Visceral Leishmaniasis
Interventions Liposomal Amphotericin B amphotericin B deoxycholate
Updated 5 times since 2017 Last updated: Apr 2, 2009 Started: Feb 29, 2008 Primary completion: Aug 31, 2008 Completion: Mar 31, 2009

This PHASE3 trial investigates Visceral Leishmaniasis and is currently completed. Banaras Hindu University leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Banaras Hindu University
Data source: Banaras Hindu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Muzaffarpur, India